Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage

To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. A case report was evaluated. A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy pre...

Full description

Saved in:
Bibliographic Details
Published in:Journal of vitreoretinal diseases (Print) 2024-11, p.24741264241297684
Main Authors: Yuan, Melissa, Hoyek, Sandra, Kim, Leo A, Chaaya, Celine, Patel, Nimesh
Format: Article
Language:English
Subjects:
Case Report
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c1974-10d85c8565996fbdffec3a733273fdfaa940d5748376dcf4340faf8ad94ad1213
container_end_page
container_issue
container_start_page 24741264241297684
container_title Journal of vitreoretinal diseases (Print)
container_volume
creator Yuan, Melissa
Hoyek, Sandra
Kim, Leo A
Chaaya, Celine
Patel, Nimesh
description To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. A case report was evaluated. A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy presented with decreased vision. Surgery was not feasible for medical reasons, and panretinal photocoagulation was limited by retinal traction and hemorrhage. Despite initial progression of bilateral macula-off, foveal-on TRDs, the patient received intravitreal (IVT) bevacizumab regularly every 8 to 12 weeks. After initial improvement, both eyes remained anatomically stable with attached foveas over more than 1.5 years of follow-up. In cases in which surgery is not possible, macula-involving TRDs with neovascularization can be managed successfully with repeated IVT anti-VEGF injection monotherapy.
doi_str_mv 10.1177/24741264241297684
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11558646</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3128828017</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1974-10d85c8565996fbdffec3a733273fdfaa940d5748376dcf4340faf8ad94ad1213</originalsourceid><addsrcrecordid>eNplUctuFDEQtBCIRCEfwAX5yIElfo3tOaFok00iBSGhAEer12NnHM2Mg-3diO_hR_FskhWIi_vhqupuFUJvKflIqVInTChBmRSsvq2SWrxAh3NvQZliL_e5FAfoOOc7QgjTijPJXqMD3jZCKEoO0e_TqYQtZLsZIOHzqYuld0OAAV-k-FB6vAJbYsJX052zJcQpY1_LCsLLPsUpWHyTHJTRTQVHjz_DrLSI3n_Aq7h1NZ3wWYC1Kzso7ESq_NfamOOZK2D7Hf1HqPO-h5Jc3GR86caYUg-37g165WHI7vgpHqFvq_Ob5eXi-svF1fL0emFpO99KOt1Y3cimbaVfd947y0FxzhT3nQdoBekaJTRXsrNecEE8eA1dK6CjjPIj9OlR936zHl1n604JBnOfwgjpl4kQzL8_U-jNbdwaSptGSyGrwvsnhRR_blwuZgzZumGAab7JcMq0ZppQVaH0EWpTzDk5v59DiZkNNv8ZXDnv_l5wz3i2k_8BVE6kTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3128828017</pqid></control><display><type>article</type><title>Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage</title><source>Sage Journals Online</source><creator>Yuan, Melissa ; Hoyek, Sandra ; Kim, Leo A ; Chaaya, Celine ; Patel, Nimesh</creator><creatorcontrib>Yuan, Melissa ; Hoyek, Sandra ; Kim, Leo A ; Chaaya, Celine ; Patel, Nimesh</creatorcontrib><description>To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. A case report was evaluated. A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy presented with decreased vision. Surgery was not feasible for medical reasons, and panretinal photocoagulation was limited by retinal traction and hemorrhage. Despite initial progression of bilateral macula-off, foveal-on TRDs, the patient received intravitreal (IVT) bevacizumab regularly every 8 to 12 weeks. After initial improvement, both eyes remained anatomically stable with attached foveas over more than 1.5 years of follow-up. In cases in which surgery is not possible, macula-involving TRDs with neovascularization can be managed successfully with repeated IVT anti-VEGF injection monotherapy.</description><identifier>ISSN: 2474-1264</identifier><identifier>ISSN: 2474-1272</identifier><identifier>EISSN: 2474-1272</identifier><identifier>DOI: 10.1177/24741264241297684</identifier><identifier>PMID: 39544710</identifier><language>eng</language><publisher>United States: SAGE Publications</publisher><subject>Case Report</subject><ispartof>Journal of vitreoretinal diseases (Print), 2024-11, p.24741264241297684</ispartof><rights>The Author(s) 2024.</rights><rights>The Author(s) 2024 2024 American Society of Retina Specialists</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1974-10d85c8565996fbdffec3a733273fdfaa940d5748376dcf4340faf8ad94ad1213</cites><orcidid>0000-0002-1601-885X ; 0000-0002-6681-6104</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39544710$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yuan, Melissa</creatorcontrib><creatorcontrib>Hoyek, Sandra</creatorcontrib><creatorcontrib>Kim, Leo A</creatorcontrib><creatorcontrib>Chaaya, Celine</creatorcontrib><creatorcontrib>Patel, Nimesh</creatorcontrib><title>Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage</title><title>Journal of vitreoretinal diseases (Print)</title><addtitle>J Vitreoretin Dis</addtitle><description>To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. A case report was evaluated. A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy presented with decreased vision. Surgery was not feasible for medical reasons, and panretinal photocoagulation was limited by retinal traction and hemorrhage. Despite initial progression of bilateral macula-off, foveal-on TRDs, the patient received intravitreal (IVT) bevacizumab regularly every 8 to 12 weeks. After initial improvement, both eyes remained anatomically stable with attached foveas over more than 1.5 years of follow-up. In cases in which surgery is not possible, macula-involving TRDs with neovascularization can be managed successfully with repeated IVT anti-VEGF injection monotherapy.</description><subject>Case Report</subject><issn>2474-1264</issn><issn>2474-1272</issn><issn>2474-1272</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNplUctuFDEQtBCIRCEfwAX5yIElfo3tOaFok00iBSGhAEer12NnHM2Mg-3diO_hR_FskhWIi_vhqupuFUJvKflIqVInTChBmRSsvq2SWrxAh3NvQZliL_e5FAfoOOc7QgjTijPJXqMD3jZCKEoO0e_TqYQtZLsZIOHzqYuld0OAAV-k-FB6vAJbYsJX052zJcQpY1_LCsLLPsUpWHyTHJTRTQVHjz_DrLSI3n_Aq7h1NZ3wWYC1Kzso7ESq_NfamOOZK2D7Hf1HqPO-h5Jc3GR86caYUg-37g165WHI7vgpHqFvq_Ob5eXi-svF1fL0emFpO99KOt1Y3cimbaVfd947y0FxzhT3nQdoBekaJTRXsrNecEE8eA1dK6CjjPIj9OlR936zHl1n604JBnOfwgjpl4kQzL8_U-jNbdwaSptGSyGrwvsnhRR_blwuZgzZumGAab7JcMq0ZppQVaH0EWpTzDk5v59DiZkNNv8ZXDnv_l5wz3i2k_8BVE6kTA</recordid><startdate>20241112</startdate><enddate>20241112</enddate><creator>Yuan, Melissa</creator><creator>Hoyek, Sandra</creator><creator>Kim, Leo A</creator><creator>Chaaya, Celine</creator><creator>Patel, Nimesh</creator><general>SAGE Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-1601-885X</orcidid><orcidid>https://orcid.org/0000-0002-6681-6104</orcidid></search><sort><creationdate>20241112</creationdate><title>Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage</title><author>Yuan, Melissa ; Hoyek, Sandra ; Kim, Leo A ; Chaaya, Celine ; Patel, Nimesh</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1974-10d85c8565996fbdffec3a733273fdfaa940d5748376dcf4340faf8ad94ad1213</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Case Report</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yuan, Melissa</creatorcontrib><creatorcontrib>Hoyek, Sandra</creatorcontrib><creatorcontrib>Kim, Leo A</creatorcontrib><creatorcontrib>Chaaya, Celine</creatorcontrib><creatorcontrib>Patel, Nimesh</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of vitreoretinal diseases (Print)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yuan, Melissa</au><au>Hoyek, Sandra</au><au>Kim, Leo A</au><au>Chaaya, Celine</au><au>Patel, Nimesh</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage</atitle><jtitle>Journal of vitreoretinal diseases (Print)</jtitle><addtitle>J Vitreoretin Dis</addtitle><date>2024-11-12</date><risdate>2024</risdate><spage>24741264241297684</spage><pages>24741264241297684-</pages><issn>2474-1264</issn><issn>2474-1272</issn><eissn>2474-1272</eissn><abstract>To evaluate the use of antivascular endothelial growth factor (anti-VEGF) as treatment for tractional retinal detachments (TRDs) involving the macula. A case report was evaluated. A 40-year-old man with a medical history notable for congenital heart disease and proliferative diabetic retinopathy presented with decreased vision. Surgery was not feasible for medical reasons, and panretinal photocoagulation was limited by retinal traction and hemorrhage. Despite initial progression of bilateral macula-off, foveal-on TRDs, the patient received intravitreal (IVT) bevacizumab regularly every 8 to 12 weeks. After initial improvement, both eyes remained anatomically stable with attached foveas over more than 1.5 years of follow-up. In cases in which surgery is not possible, macula-involving TRDs with neovascularization can be managed successfully with repeated IVT anti-VEGF injection monotherapy.</abstract><cop>United States</cop><pub>SAGE Publications</pub><pmid>39544710</pmid><doi>10.1177/24741264241297684</doi><orcidid>https://orcid.org/0000-0002-1601-885X</orcidid><orcidid>https://orcid.org/0000-0002-6681-6104</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2474-1264
ispartof Journal of vitreoretinal diseases (Print), 2024-11, p.24741264241297684
issn 2474-1264
2474-1272
2474-1272
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11558646
source Sage Journals Online
subjects Case Report
title Antivascular Endothelial Growth Factor Injections for the Chronic Treatment of Macula-off, Fovea-on Diabetic Tractional Retinal Detachment With Vitreous Hemorrhage
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T14%3A37%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antivascular%20Endothelial%20Growth%20Factor%20Injections%20for%20the%20Chronic%20Treatment%20of%20Macula-off,%20Fovea-on%20Diabetic%20Tractional%20Retinal%20Detachment%20With%20Vitreous%20Hemorrhage&rft.jtitle=Journal%20of%20vitreoretinal%20diseases%20(Print)&rft.au=Yuan,%20Melissa&rft.date=2024-11-12&rft.spage=24741264241297684&rft.pages=24741264241297684-&rft.issn=2474-1264&rft.eissn=2474-1272&rft_id=info:doi/10.1177/24741264241297684&rft_dat=%3Cproquest_pubme%3E3128828017%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1974-10d85c8565996fbdffec3a733273fdfaa940d5748376dcf4340faf8ad94ad1213%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3128828017&rft_id=info:pmid/39544710&rfr_iscdi=true